Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Adapalene 0.3% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris
NCT01880320Phase 3Completed
- Sponsor
- Galderma
- Start
- Jul 2013
- Primary completion
- Mar 2014
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of adapalene, benzoyl peroxide + sulfur in acne vulgaris, sponsored by Galderma. Started Jul 2013; status: completed.
02
Drugs
adapalenebenzoyl peroxide + sulfur
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01880320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01880320.